Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 37

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 37
---
fusion Class B Common Stock represented at the Special Meeting is required to approve the Adjournment Proposal. |

As of the record date, Enfusion directors and executive officers, as a group, owned and were entitled to vote shares of Enfusion Common Stock and Enfusion Class B Common Stock, or approximately % of the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock. Enfusion currently expects that these directors and executive officers will vote their shares in favor of approving the Merger Agreement Proposal and the Adjournment Proposal, although none of them are obligated to do so, other than Oleg Movchan with respect to the Merger Agreement Proposal and the Adjournment Proposal. Concurrently with the execution of the Merger Agreement, each of the Significant Stockholders have agreed to vote all of the shares of Enfusion Common Stock and Enfusion Class B Common Stock held by them (representing in the aggregate approximately % of the total outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock as of the record date) in favor of the Merger Agreement Proposal, as described in more detail in the section titled “The Support Agreements.” Enfusion’s Reasons for the Transactions; Recommendations of the Special Committee and Enfusion Board(see page 76) Recommendations of the Special Committee On January 10, 2025, the special committee (the “ Special Committee”) of the Enfusion Board unanimously (i) concluded that the terms and conditions of the Merger Agreement, the Mergers and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Enfusion and Enfusion Stockholders, (ii) recommended that the Enfusion Board (a) adopt a resolution (x) adopting and approving (including for purposes of Section 203 of the DGCL), the Merger Agreement, the Mergers and the other transactions contemplated by the Merger Agreement and (y) declaring that the Merger Agreement, the Mergers and the other transactions contemplated by the Merger Agreement are advisable, fair to and in the best interests of Enfusion and Enfusion Stockholders, and (b) recommended that the Enfusion Stockholders adopt the Merger Agreement and approve the transactions contemplated by the Merger Agreement, including the Mergers, (iii) recommended that the Enfusion Board adopt a resolution recommending that the Enfusion Stockholders vote their shares in favor of adopting the Merger Agreement at a special meeting of the Enfusion Stockholders. Recommendations of the Enfusion Board The